Cost-effectiveness of dexamethasone compared with aflibercept in naïve diabetic macular edema.

Saved in:
Bibliographic Details
Title: Cost-effectiveness of dexamethasone compared with aflibercept in naïve diabetic macular edema.
Authors: Montes Rodríguez P; Department of Ophthalmology, Hospital Clínico Universitario 'Lozano Blesa'', Zaragoza, Spain. pmontes.1@alumni.unav.es.; Aragon Health Research Institute (IIS Aragon), Zaragoza, Spain. pmontes.1@alumni.unav.es., Mateo Gabás J; Department of Ophthalmology, Hospital Clínico Universitario 'Lozano Blesa'', Zaragoza, Spain.; Aragon Health Research Institute (IIS Aragon), Zaragoza, Spain., Esteban Floría O; Department of Ophthalmology, Hospital Clínico Universitario 'Lozano Blesa'', Zaragoza, Spain.; Aragon Health Research Institute (IIS Aragon), Zaragoza, Spain., Honrubia Grijalbo A; Department of Ophthalmology, Hospital Clínico Universitario 'Lozano Blesa'', Zaragoza, Spain.; Aragon Health Research Institute (IIS Aragon), Zaragoza, Spain., Ascaso Puyuelo FJ; Department of Ophthalmology, Hospital Clínico Universitario 'Lozano Blesa'', Zaragoza, Spain.; Aragon Health Research Institute (IIS Aragon), Zaragoza, Spain.
Source: Cost effectiveness and resource allocation : C/E [Cost Eff Resour Alloc] 2022 Dec 01; Vol. 20 (1), pp. 61. Date of Electronic Publication: 2022 Dec 01.
Publication Type: Journal Article
Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101170476 Publication Model: Electronic Cited Medium: Print ISSN: 1478-7547 (Print) Linking ISSN: 14787547 NLM ISO Abbreviation: Cost Eff Resour Alloc Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1478-7547
DOI:10.1186/s12962-022-00401-z